Nuvalent, Inc. (NUVL)

105.84 +1.01 (+0.96%) USD  |  NASDAQ  |  Dec 24, 12:59
105.90 +0.06 (+0.06%) After-Hours: 13:59
More

Nuvalent SG&A Expense (TTM): 89.78M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Boston Scientific Corp. 6.666B
Pfizer Inc. 13.91B
Xencor, Inc. 61.52M
Glaukos Corp. 306.05M
NovaBay Pharmaceuticals, Inc. 8.584M